Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Related Citations for PubMed (Select 19276049)

1.

Vascular pathology in male Lewis rats following short-term, low-dose rotenone administration.

Allen AL, Luo C, Montgomery DL, Rajput AH, Robinson CA, Rajput A.

Vet Pathol. 2009 Jul;46(4):776-82. doi: 10.1354/vp.08-VP-0114-A-AM. Epub 2009 Mar 9.

2.

The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments.

Ravenstijn PG, Merlini M, Hameetman M, Murray TK, Ward MA, Lewis H, Ball G, Mottart C, de Ville de Goyet C, Lemarchand T, van Belle K, O'Neill MJ, Danhof M, de Lange EC.

J Pharmacol Toxicol Methods. 2008 Mar-Apr;57(2):114-30. Epub 2007 Nov 13.

PMID:
18155613
3.

Sleep disturbances in the rotenone animal model of Parkinson disease.

García-García F, Ponce S, Brown R, Cussen V, Krueger JM.

Brain Res. 2005 May 3;1042(2):160-8.

PMID:
15854587
4.

Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease.

Caboni P, Sherer TB, Zhang N, Taylor G, Na HM, Greenamyre JT, Casida JE.

Chem Res Toxicol. 2004 Nov;17(11):1540-8.

PMID:
15540952
5.

Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication.

Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, Greenamyre JT.

J Biol Chem. 2005 Dec 23;280(51):42026-35. Epub 2005 Oct 21.

6.

Vascular damage mediates neuronal and non-neuronal pathology following short and long-term rotenone administration in Sprague-Dawley rats.

Radad K, Hassanein K, Moldzio R, Rausch WD.

Exp Toxicol Pathol. 2013 Jan;65(1-2):41-7. doi: 10.1016/j.etp.2011.05.008. Epub 2011 Jun 14.

PMID:
21676605
7.

Alpha-synuclein and tyrosine hydroxylase expression in acute rotenone toxicity.

Luo C, Rajput AH, Akhtar S, Rajput A.

Int J Mol Med. 2007 Mar;19(3):517-21.

PMID:
17273802
8.

Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.

Ulusoy GK, Celik T, Kayir H, Gürsoy M, Isik AT, Uzbay TI.

Brain Res Bull. 2011 Jul 15;85(6):380-4. doi: 10.1016/j.brainresbull.2011.05.001. Epub 2011 May 11.

PMID:
21600965
9.

Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology.

Drolet RE, Cannon JR, Montero L, Greenamyre JT.

Neurobiol Dis. 2009 Oct;36(1):96-102. doi: 10.1016/j.nbd.2009.06.017. Epub 2009 Jul 10.

PMID:
19595768
10.

Increased myocardial N-myristoyltransferase activity in rotenone model of Parkinsonism.

Pasha MK, Sharma RK, Rajput AH.

Int J Mol Med. 2005 Jun;15(6):987-91.

PMID:
15870904
11.

Arterial baroreflex dysfunction fails to mimic Parkinson's disease in rats.

Yu JG, Wu J, Shen FM, Cai GJ, Liu JG, Su DF.

J Pharmacol Sci. 2008 Sep;108(1):56-62. Epub 2008 Sep 6.

12.

Sesamol and naringenin reverse the effect of rotenone-induced PD rat model.

Sonia Angeline M, Sarkar A, Anand K, Ambasta RK, Kumar P.

Neuroscience. 2013 Dec 19;254:379-94. doi: 10.1016/j.neuroscience.2013.09.029. Epub 2013 Sep 24.

PMID:
24070629
13.

Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.

Verma R, Nehru B.

Neurochem Int. 2009 Nov;55(6):369-75. doi: 10.1016/j.neuint.2009.04.001. Epub 2009 Apr 16.

PMID:
19375462
14.

Effect of malate on the development of rotenone-induced brain changes in Wistar and OXYS rats: An MRI study.

Kolosova NG, Akulov AE, Stefanova NA, Moshkin MP, Savelov AA, Koptyug IV, Panov AV, Vavilin VA.

Dokl Biol Sci. 2011 Mar-Apr;437:72-5. doi: 10.1134/S0012496611020049. Epub 2011 May 12. No abstract available.

PMID:
21562948
15.

Lessons from the rotenone model of Parkinson's disease.

Greenamyre JT, Cannon JR, Drolet R, Mastroberardino PG.

Trends Pharmacol Sci. 2010 Apr;31(4):141-2; author reply 142-3. doi: 10.1016/j.tips.2009.12.006. Epub 2010 Jan 22. Review. No abstract available.

16.

Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.

Alam M, Danysz W, Schmidt WJ, Dekundy A.

Toxicol Appl Pharmacol. 2009 Oct 15;240(2):198-207. doi: 10.1016/j.taap.2009.07.010. Epub 2009 Jul 17.

PMID:
19616571
17.

Pesticide use linked to Parkinson's disease.

Adam D.

Nature. 2000 Nov 9;408(6809):125. No abstract available.

PMID:
11089940
18.

Overexpression of Kir2.3 in PC12 cells resists rotenone-induced neurotoxicity associated with PKC signaling pathway.

Wang G, Zeng J, Shen CY, Wang ZQ, Chen SD.

Biochem Biophys Res Commun. 2008 Sep 19;374(2):204-9. doi: 10.1016/j.bbrc.2008.07.003. Epub 2008 Jul 11.

PMID:
18619942
19.

Vascular changes in acute Wernicke's encephalopathy.

Okeda R, Taki K, Ikari R, Funata N.

Acta Neuropathol. 1995;89(5):420-4.

PMID:
7618440
20.

Mitochondrial toxins and neurodegenerative diseases.

Ayala A, Venero JL, Cano J, Machado A.

Front Biosci. 2007 Jan 1;12:986-1007. Review.

PMID:
17127354
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk